Tislelizumab with Azacitidine in the Treatment of R/R AML
Clinical trial NCT06586099 · WITHDRAWN
Trial details
- NCT number
- NCT06586099
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-05
- Primary completion
- 2025-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.